{"id":55685,"date":"2023-04-11T16:03:33","date_gmt":"2023-04-11T14:03:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/"},"modified":"2023-04-11T16:03:33","modified_gmt":"2023-04-11T14:03:33","slug":"bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/","title":{"rendered":"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023"},"content":{"rendered":"
\n

\nBostonGene to Present on <\/i>the Power of Next-generation Immunotherapy Response Prediction Using AI-based Multiomic Data Integration<\/i><\/p>\n

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene<\/a> today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023, which will be held from April 14 \u2013 19, at the Orange County Convention Center in Orlando, FL. <\/strong>BostonGene will exhibit at booth #1358.<\/p>\n

<\/a><\/p>\n

\nOn Sunday, April 16, Alexander Bagaev, PhD, Vice President of Product Development at BostonGene, will deliver a presentation on the power of next-generation immunotherapy response prediction driven by BostonGene\u2019s bioinformatic engine through AI-based multiomic data integration.<\/p>\n

\nBostonGene will present posters that describe the development of novel assays and analytical tools and pipelines to advance precision oncology, including our liquid biopsy platform and cancer of unknown primary (CUP) classifier. BostonGene will also demonstrate ability of comprehensive molecular profiling to identify clinically relevant alterations that can be utilized for treatment decision-making. The presentations highlight the application of BostonGene\u2019s innovative technologies to improve the diagnosis and personalized treatment recommendations for cancer patients.<\/p>\n

\nDetails of BostonGene\u2019s presence at the AACR Annual Meeting are below:<\/p>\n

\nSpotlight Theater Presentation:<\/b><\/p>\n

\nTitle:<\/b> Next generation immunotherapy response prediction driven by BostonGene\u2019s bioinformatic engine through AI-based multiomic data integration<\/a>
Date and Time: <\/b>Sunday, April 16 | 1:30 PM
\n
Location:<\/b> Spotlight theater C
\n
Speaker: <\/b>Alexander Bagaev, PhD, Vice President of Product Development, BostonGene<\/i><\/p>\n

\nBostonGene uses artificial intelligence and machine learning systems to integrate data from next-generation DNA and RNA sequencing (NGS), multiplex imaging, and flow cytometry to paint a comprehensive portrait of a cancer patient\u2019s tumor and immune system. This 360-degree approach to precision diagnostics requires the deployment of novel analytical solutions.<\/p>\n

\nPoster Presentations:<\/b><\/p>\n

\nTitle: <\/b>Use of comprehensive molecular profiling to identify additional clinically-relevant alterations compared to targeted gene panels<\/a>
Abstract number: <\/b>244
\n
Date and Time:<\/b> Sunday, April 16 | 1:30 PM \u2013 5:00 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 9
\n
Presenter:<\/b> Sandrine Degryse, PhD, BostonGene<\/i><\/p>\n

\nTitle: <\/b>Analytical validation of a liquid biopsy test using cell-free circulating tumor DNA for mutational profiling<\/a>
Abstract number: <\/b>1042
\n
Date and Time:<\/b> Sunday, April 16 | 1:30 PM \u2013 5:00 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 42
\n
Presenter:<\/b> Anastasia Yudina, BostonGene<\/i><\/p>\n

\nTitle:<\/b> <\/b>Integrated analysis of gene expression signatures and AI-based detection of tertiary lymphoid structures and stromal tumor-infiltrating lymphocytes in breast cancer H&E samples<\/a>
Abstract number: <\/b>27
\n
Date and Time:<\/b> Tuesday, April 18 | 1:30 PM \u2013 5:00 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 33
\n
Presenter:<\/b> Kate Postovalova, PhD, BostonGene<\/i><\/p>\n

\nTitle: <\/b>An ML-based tool for predicting tissue of origin for cancer of unknown primary (CUP) based on genomic and transcriptomic data<\/a>
Abstract number: <\/b>5405
\n
Date and Time: <\/b>Tuesday, April 18 | 1:30 PM \u2013 5:00 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 32
\n
Presenter: <\/b>Nara Shin, PhD, BostonGene<\/i><\/p>\n

\nTitle: <\/b>Computational cancer cell gene expression deconvolution from tumor bulk RNA-seq via the machine learning algorithm Helenus<\/a>
Abstract number:<\/b> 5401
\n
Date and Time:<\/b> Tuesday, April 18 | 1:30 PM \u2013 5:00 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 32
\n
Presenter:<\/b> Krystle Nomie, PhD, BostonGene<\/i><\/p>\n

\nTitle:<\/b> Development and refinement of functional gene expression signatures as a computational tool for comprehensive characterization of transcriptomic data<\/a>
Abstract number: <\/b>6538
\n
Date and Time: <\/b>Wednesday, April 19 | 9:00 AM \u2013 12:30 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 30
\n
Presenter:<\/b> Alexander Bagaev, PhD, BostonGene<\/i><\/p>\n

\nTitle: <\/b>Comprehensive immunoprofiling of peripheral blood reveals five conserved immunotypes with implications for immunotherapy in cancer patients<\/a>
Abstract number: <\/b>6664
\n
Date and Time:<\/b> Wednesday, April 19 | 9:00 AM \u2013 12:30 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 39
\n
Presenter:<\/b> Michael Goldberg, PhD, BostonGene<\/i><\/p>\n

\nTitle:<\/b> Cancer of unknown primary (CUP): Beyond the identification of the site of origin by an integrative genomic approach<\/a>
Abstract number: <\/b>2143
\n
Date and Time: <\/b>Monday, April 17 | 9:00 AM \u2013 12:30 PM
\n
Location: <\/b>Exhibit Hall, Poster Section 39
\n
Presenter:<\/b> Majd Al Assaad, MD, Weill Cornell Medicine<\/i><\/p>\n

\nResearch conducted in collaboration with Weill Cornell Medicine<\/i><\/p>\n

\nThe abstracts will be published in an online-only Proceedings supplement to the AACR journal Cancer Research<\/i> after the conclusion of the AACR Annual Meeting.<\/p>\n

\nAbout BostonGene Corporation<\/b><\/p>\n

\nBostonGene\u2019s mission is to power healthcare\u2019s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce overall cost of cancer care. BostonGene\u2019s tests <\/sup>reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene\u2019s tests generate a personalized roadmap for therapeutic decision-making for each cancer patient. For more information, visit BostonGene at http:\/\/www.BostonGene.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
BostonGene<\/b>
Erin O\u2019Reilly
\n
+1-617-283-2285
\n
Erin.Oreilly@BostonGene.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BostonGene to Present on the Power of Next-generation Immunotherapy Response Prediction Using AI-based Multiomic Data Integration WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023, which will be held from April 14 \u2013 19, at the Orange County Convention Center … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55685","6":"format-standard","7":"category-industry"},"yoast_head":"\nBostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BostonGene to Present on the Power of Next-generation Immunotherapy Response Prediction Using AI-based Multiomic Data Integration WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023, which will be held from April 14 \u2013 19, at the Orange County Convention Center ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-11T14:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230411005172\/en\/821014\/21\/bostongene-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023\",\"datePublished\":\"2023-04-11T14:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/\"},\"wordCount\":732,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005172\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/\",\"name\":\"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005172\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\",\"datePublished\":\"2023-04-11T14:03:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005172\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005172\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/","og_locale":"en_US","og_type":"article","og_title":"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023 - Pharma Trend","og_description":"BostonGene to Present on the Power of Next-generation Immunotherapy Response Prediction Using AI-based Multiomic Data Integration WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023, which will be held from April 14 \u2013 19, at the Orange County Convention Center ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-11T14:03:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230411005172\/en\/821014\/21\/bostongene-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023","datePublished":"2023-04-11T14:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/"},"wordCount":732,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005172\/en\/821014\/21\/bostongene-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/","url":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/","name":"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005172\/en\/821014\/21\/bostongene-logo.jpg","datePublished":"2023-04-11T14:03:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230411005172\/en\/821014\/21\/bostongene-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230411005172\/en\/821014\/21\/bostongene-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bostongene-announces-acceptance-of-eight-abstracts-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55685"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55685\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}